Name: UMIN ID:
Unique ID issued by UMIN | UMIN000039226 |
---|---|
Receipt number | R000044736 |
Scientific Title | Characterizing the cross-sectional approach to investigate the prevalence of tissue BRCA1/2 mutations in newly diagnosed advanced ovarian cancer patients |
Date of disclosure of the study information | 2020/01/27 |
Last modified on | 2022/07/28 16:51:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/01/22 13:22:18 | ||
2 | Update | 2020/02/05 09:11:32 | Institutions |
|
3 | Update | 2020/02/25 18:58:51 | Other related information |
|
4 | Update | 2020/03/24 18:19:31 | Other related information |
|
5 | Update | 2020/03/24 18:37:15 | Recruitment status Date of IRB Anticipated trial start date |
|
6 | Update | 2021/01/26 09:16:56 | Recruitment status Last follow-up date Date of closure to data entry |
|
7 | Update | 2021/03/31 17:46:09 | Name of person sending information Name of person sending information Address Address TEL |
|
8 | Update | 2021/07/27 11:27:19 | Institutions |
|
9 | Update | 2021/12/16 15:25:44 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
10 | Update | 2022/07/28 16:51:22 | Recruitment status |